Last €139.96 EUR
Change Today +1.17 / 0.84%
Volume 20.0
XP2 On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 7:39 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by SALIX PHARMACEUTICALS LTD (XP2) in the last 6 months

Announced 02/22/15
13.31B for Salix Pharmaceuticals Ltd.
Merger/Acquisition

Valeant Pharmaceuticals International entered into a definitive agreement to acquire Salix Pharmaceuticals Ltd. (NasdaqGS:SLXP) from Fidelity Management & Research Company, HealthCor Management L.P., Paulson & Co. Inc., Visium Asset Management, LLC, Franklin Resources, Inc. and others for $10.4 billion in cash on February 20, 2015. The transaction is structured as a tender offer and Valeant will pay $158 per share as purchase consideration for each common stock and restricted ...
Read More


XP2's price was unchanged after the transaction was announced on 02/22/15.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XP2:GR €139.96 EUR +1.17

XP2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $70.75 USD -0.72
Jazz Pharmaceuticals PLC $173.95 USD -0.47
Lupin Ltd 1,802 INR +5.40
Recordati SpA €16.14 EUR -0.10
Santen Pharmaceutical Co Ltd ¥8,180 JPY +220.00
View Industry Companies
 

Industry Analysis

XP2

Industry Average

Valuation XP2 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.3x
Price/Book 19.0x
Price/Cash Flow 101.0x
TEV/Sales 4.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SALIX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.